Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 2, 2024 · 10-Q · 32 days after period end · 0001213900-24-038757
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$11.10M | -$9.05M | -$10.76M | -$13.47M |
| EPS Diluted | -$0.97 | -$0.80 | -$0.96 | -$1.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 2, 2024 · 32 d after period end
